Skip to main content

Table 2 Recommended dose for posaconazole in renal and liver impairment patients [12]

From: A case report of intravenous posaconazole in hepatic and renal impairment patient with invasive Aspergillus terreus infection: safety and role of therapeutic drug monitoring

Population

Posaconazole dose adjustment

Renal impairment

 

Creatinine clearance 20-80 ml/min

No adjustment necessary

Creatinine clearance < 20 ml/min

No adjustment necessary, monitor for breakthrough fungal infections due to variability in exposure

Hepatic impairment

 

Child-Pugh A, B, C

No adjustment necessary